Literature DB >> 28143773

The AGA's Fecal Microbiota Transplantation National Registry: An Important Step Toward Understanding Risks and Benefits of Microbiota Therapeutics.

Colleen R Kelly1, Alison M Kim2, Loren Laine3, Gary D Wu4.   

Abstract

Mesh：

Year:  2017        PMID： 28143773     DOI： 10.1053/j.gastro.2017.01.028

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  20 in total

Review 1.  Fecal Microbiota Transplantation: Beyond Clostridium difficile.

Authors:  Braden Millan; Michael Laffin; Karen Madsen
Journal:  Curr Infect Dis Rep       Date:  2017-09       Impact factor: 3.725

Review 2.  The Present Status of Fecal Microbiota Transplantation and Its Value in the Elderly.

Authors:  Yao-Wen Cheng; Monika Fischer
Journal:  Curr Treat Options Gastroenterol       Date:  2017-09

3.  Durability and Long-term Clinical Outcomes of Fecal Microbiota Transplant Treatment in Patients With Recurrent Clostridium difficile Infection.

Authors:  Yafet Mamo; Michael H Woodworth; Tiffany Wang; Tanvi Dhere; Colleen S Kraft
Journal:  Clin Infect Dis       Date:  2018-05-17       Impact factor: 9.079

4.  Ethical Considerations in Microbial Therapeutic Clinical Trials.

Authors:  Michael H Woodworth; Kaitlin L Sitchenko; Cynthia Carpentieri; Rachel J Friedman-Moraco; Tiffany Wang; Colleen S Kraft
Journal:  New Bioeth       Date:  2017-10-17

Review 5.  A framework for microbiome science in public health.

Authors:  Jeremy E Wilkinson; Eric A Franzosa; Christine Everett; Chengchen Li; Frank B Hu; Dyann F Wirth; Mingyang Song; Andrew T Chan; Eric Rimm; Wendy S Garrett; Curtis Huttenhower
Journal:  Nat Med       Date:  2021-04-05       Impact factor: 53.440

Review 6.  Intervention strategies for microbial therapeutics in cancer immunotherapy.

Authors:  V Gopalakrishnan; B Weiner; C B Ford; B R Sellman; S A Hammond; D J Freeman; P Dennis; J-C Soria; J R Wortman; M R Henn
Journal:  Immunooncol Technol       Date:  2020-05-20

7.  Intestinal Dopamine Receptor D2 is Required for Neuroprotection Against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Dopaminergic Neurodegeneration.

Authors:  Hairong Peng; Shui Yu; Yukai Zhang; Yanqing Yin; Jiawei Zhou
Journal:  Neurosci Bull       Date:  2022-04-11       Impact factor: 5.271

8.  Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience.

Authors:  Yao-Wen Cheng; Emmalee Phelps; Vincent Ganapini; Noor Khan; Fangqian Ouyang; Huiping Xu; Sahil Khanna; Raseen Tariq; Rachel J Friedman-Moraco; Michael H Woodworth; Tanvi Dhere; Colleen S Kraft; Dina Kao; Justin Smith; Lien Le; Najwa El-Nachef; Nirmal Kaur; Sree Kowsika; Adam Ehrlich; Michael Smith; Nasia Safdar; Elizabeth Ann Misch; Jessica R Allegretti; Ann Flynn; Zain Kassam; Asif Sharfuddin; Raj Vuppalanchi; Monika Fischer
Journal:  Am J Transplant       Date:  2018-08-31       Impact factor: 8.086

Review 9.  Fecal Microbiota Transplantation Donor Screening Updates and Research Gaps for Solid Organ Transplant Recipients.

Authors:  Nirja Mehta; Tiffany Wang; Rachel J Friedman-Moraco; Cynthia Carpentieri; Aneesh K Mehta; Nadine Rouphael; Tanvi Dhere; Christian P Larsen; Colleen S Kraft; Michael H Woodworth
Journal:  J Clin Microbiol       Date:  2021-06-16       Impact factor: 11.677

Review 10.  Fecal microbiota transplantation and its potential therapeutic uses in gastrointestinal disorders.

Authors:  Ryan D Heath; Courtney Cockerell; Ravinder Mankoo; Jamal A Ibdah; Veysel Tahan
Journal:  North Clin Istanb       Date:  2018-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.